Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Patrick Marcellin, Edward Gane, Nezam H. Afdhal et al. · The Lancet · 2012 · 1.8K citations

Medicine, Pharmacology, Pharmacotherapy +16

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

Bart J. Veldt, Jordan J. Feld, Heiner Wedemeyer et al. · JAMA · 2012 · 1.5K citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

Kris V. Kowdley, Stuart C. Gordon, K. Rajender Reddy et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Bryce D. Smith, Rebecca L. Morgan, Geoff A. Beckett et al. · PubMed · 2012 · 998 citations

Medicine, Infectious Disease Control, Infectious Diseases +13